Profile
Douglas Jacobstein is Vice President-Clinical Development at Provention Bio, Inc. since 2019.
Dr. Jacobstein is Senior VP & Global Head-Clinical Development at Abivax SA since 2023.
Formerly, Dr. Jacobstein was Senior Director-Medical Affairs at Osiris Therapeutics, Inc. from 2009 to 2013.
Dr. Jacobstein was Director-Clinical Development & Medical Affairs at Alba Therapeutics Corp.
Education includes undergraduate studies at Cornell University and a doctorate from the University of Maryland.
Douglas Jacobstein active positions
| Companies | Position | Start |
|---|---|---|
| PROVENTION BIO, INC. | Corporate Officer/Principal | 02/04/2019 |
| ABIVAX | Chief Tech/Sci/R&D Officer | 01/10/2023 |
Former positions of Douglas Jacobstein
| Companies | Position | End |
|---|---|---|
Alba Therapeutics Corp.
Alba Therapeutics Corp. Pharmaceuticals: MajorHealth Technology Discovers, develops and markets pharmaceutical products | Chief Tech/Sci/R&D Officer | - |
| OSIRIS THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | - |
Training of Douglas Jacobstein
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 6 |
|---|---|
Osiris Therapeutics, Inc.
Osiris Therapeutics, Inc. BiotechnologyHealth Technology Researches and develops therapeutic products for the regeneration of human connective tissues | Health Technology |
Alba Therapeutics Corp.
Alba Therapeutics Corp. Pharmaceuticals: MajorHealth Technology Discovers, develops and markets pharmaceutical products | Health Technology |
Cornell University
Cornell University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Maryland
University of Maryland Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Abivax SA
Abivax SA Pharmaceuticals: OtherHealth Technology Operates biotechnology company which develops therapeutics that harness the body’s natural regulatory mechanisms | Health Technology |
Provention Bio, Inc.
Provention Bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company that engages in intercepting and preventing immune-mediated diseases including type 1 diabetic activities | Health Technology |
- Stock Market
- Insiders
- Douglas Jacobstein
















